Related Experiment Video
Updated: May 1, 2026
09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
2.0K
Identification of Alzheimer's disease subtypes and biomarkers from human multi-omics data using subspace merging
Ziyan Song1, Xiaoqing Huang1, Asha Jacob Jannu2,3
1Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Summary
Researchers identified distinct Alzheimer's disease (AD) subtypes using multi-omics data integration. These subtypes reveal molecular mechanisms driving AD heterogeneity and inform personalized treatment strategies.
Area of Science:
- Neuroscience
- Genomics
- Biochemistry
Background:
- Alzheimer's disease (AD) is a complex, heterogeneous neurodegenerative disorder with varied progression and pathology.
- Understanding AD heterogeneity is crucial for elucidating disease etiology and developing targeted therapies.
Purpose of the Study:
- To identify distinct, data-driven Alzheimer's disease subtypes by integrating multi-omics data.
- To characterize the subtype-specific molecular biology and link it to clinical phenotypes.
Main Methods:
- Applied a subspace-merging algorithm to integrate multi-omics data from three large Alzheimer's disease cohorts.
- Performed subtype-specific biological analyses and a Phenome-wide Association Study (PheWAS) of expression quantitative trait loci (eQTLs).
Main Results:
- Identified Alzheimer's disease subtypes exhibiting distinct cognitive and pathological features across cohorts.
- Highlighted the involvement of synaptic and neurotransmission pathways.
- Revealed significant associations between molecular differences and disease phenotypes via PheWAS.
Conclusions:
- The developed algorithm successfully integrated multi-modal data for patient clustering and subtype identification.
- Transcriptomic signatures offer insights into Alzheimer's disease heterogeneity.
- Findings pave the way for personalized Alzheimer's disease treatment approaches.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35